alto-300
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Nov 30, 2021 (NCT05118750)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05922878 | Phase 2 | Jun 8, 2023 | Alto Neuroscience |
| NCT05157945 | Phase 2 | Dec 31, 2021 | Alto Neuroscience |
| NCT05118750 | Phase 2 | Nov 30, 2021 | Alto Neuroscience |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Alto Neuroscience | For profit | 3 | 3 | 1 | 2021 |
1 organizations
Page 1 / 1